ATE154937T1 - Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung - Google Patents

Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung

Info

Publication number
ATE154937T1
ATE154937T1 AT93302937T AT93302937T ATE154937T1 AT E154937 T1 ATE154937 T1 AT E154937T1 AT 93302937 T AT93302937 T AT 93302937T AT 93302937 T AT93302937 T AT 93302937T AT E154937 T1 ATE154937 T1 AT E154937T1
Authority
AT
Austria
Prior art keywords
substituted alkyl
treatment
alkyl
prostatic
hypertrophics
Prior art date
Application number
AT93302937T
Other languages
English (en)
Inventor
Koichi Kojima
Hitoshi Kurata
Koki Ishibashi
Takakazu Hamada
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE154937T1 publication Critical patent/ATE154937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
AT93302937T 1992-04-20 1993-04-15 Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung ATE154937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9981692 1992-04-20
JP32804392 1992-12-08

Publications (1)

Publication Number Publication Date
ATE154937T1 true ATE154937T1 (de) 1997-07-15

Family

ID=26440917

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93302937T ATE154937T1 (de) 1992-04-20 1993-04-15 Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung

Country Status (25)

Country Link
US (3) US5536714A (de)
EP (2) EP0567271B1 (de)
JP (1) JP2514778B2 (de)
KR (1) KR0146680B1 (de)
CN (2) CN1041095C (de)
AT (1) ATE154937T1 (de)
AU (1) AU656852B2 (de)
CA (1) CA2094300C (de)
CZ (2) CZ284206B6 (de)
DE (1) DE69311837T2 (de)
DK (1) DK0567271T3 (de)
ES (1) ES2105108T3 (de)
FI (1) FI931765A (de)
GR (1) GR3024896T3 (de)
HK (1) HK1000303A1 (de)
HU (1) HU219579B (de)
ID (1) ID18576A (de)
IL (1) IL105478A (de)
MX (1) MX9302300A (de)
NO (1) NO304891B1 (de)
NZ (1) NZ247449A (de)
PH (1) PH31052A (de)
RU (2) RU2114861C1 (de)
TW (2) TW238312B (de)
ZA (1) ZA932732B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
CZ266694A3 (en) * 1992-04-30 1995-07-12 Smithkline Beecham Corp Derivatives of estra-1,3,5(10)-triene-3-carboxylic acid, process of their preparation, their use in the preparation of pharmaceutical preparations and pharmaceutical compositions containing thereof
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
CN1133005A (zh) * 1993-09-03 1996-10-09 史密丝克莱恩比彻姆公司 稳定的片剂
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
GB9411103D0 (en) * 1994-06-03 1994-07-27 Smithkline Beecham Corp Compounds
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US6428769B1 (en) 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
WO2003029268A1 (en) * 2001-10-03 2003-04-10 Merck & Co., Inc. Androstane 17-beta-carboxamides as androgen receptor modulators
AU2002361861A1 (en) * 2001-12-21 2003-07-30 Rhode Island Hospital SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
US20060148725A1 (en) * 2001-12-21 2006-07-06 The Miriam Hospital Selective 11beta HSD inhibitors and methods of use thereof
WO2004097002A2 (en) * 2003-04-29 2004-11-11 The Miriam Hospital SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US7604386B2 (en) * 2005-11-18 2009-10-20 Federal-Mogul World Wide, Inc Lamp assembly having a socket made from high temperature plastic
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US8563728B2 (en) * 2009-07-09 2013-10-22 Aurobindo Pharma Ltd. Process for the preparation of Dutasteride
CN111362999B (zh) * 2020-03-16 2022-03-29 江苏联环药业股份有限公司 一种爱普列特杂质及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
IL74365A (en) * 1984-02-27 1990-07-26 Merck & Co Inc 17beta-(n-t.-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one and pharmaceutical compositions containing it
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
WO1992018132A1 (en) * 1991-04-17 1992-10-29 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
EP0725074A3 (de) 1996-11-20
JPH06279487A (ja) 1994-10-04
FI931765A (fi) 1993-10-21
DK0567271T3 (da) 1998-02-16
PH31052A (en) 1998-02-03
AU3698493A (en) 1993-10-21
RU95101838A (ru) 1997-01-10
TW238312B (de) 1995-01-11
NO931401L (no) 1993-10-21
IL105478A0 (en) 1993-08-18
NO931401D0 (no) 1993-04-16
CZ90097A3 (cs) 1998-07-15
HU9301155D0 (en) 1993-07-28
CA2094300A1 (en) 1993-10-21
EP0725074A2 (de) 1996-08-07
KR0146680B1 (ko) 1998-08-01
EP0567271A2 (de) 1993-10-27
NZ247449A (en) 1995-02-24
EP0567271B1 (de) 1997-07-02
ES2105108T3 (es) 1997-10-16
CA2094300C (en) 2003-01-28
US5717088A (en) 1998-02-10
HK1000303A1 (en) 1998-02-20
DE69311837D1 (de) 1997-08-07
JP2514778B2 (ja) 1996-07-10
IL105478A (en) 1998-03-10
CZ284206B6 (cs) 1998-09-16
RU2114861C1 (ru) 1998-07-10
US5536714A (en) 1996-07-16
ZA932732B (en) 1993-10-28
ID18576A (id) 1998-04-23
CN1041095C (zh) 1998-12-09
GR3024896T3 (en) 1998-01-30
MX9302300A (es) 1994-03-31
CN1083070A (zh) 1994-03-02
AU656852B2 (en) 1995-02-16
RU2097387C1 (ru) 1997-11-27
HUT64558A (en) 1994-01-28
CZ283791B6 (cs) 1998-06-17
FI931765A0 (fi) 1993-04-19
CN1195666A (zh) 1998-10-14
US5760025A (en) 1998-06-02
NO304891B1 (no) 1999-03-01
DE69311837T2 (de) 1998-02-12
CZ67893A3 (en) 1994-01-19
HU219579B (hu) 2001-05-28
KR930021654A (ko) 1993-11-22
EP0567271A3 (de) 1994-11-23
TW401420B (en) 2000-08-11

Similar Documents

Publication Publication Date Title
DE69311837T2 (de) Steroide zur Behandlung von Prostatisch-Hypertrophe, ihre Herstellung und Verwendung
DE69120500D1 (de) Azasteroide zur Behandlung prostatischer Hypertrophie, ihre Herstellung und Verwendung
AU4224993A (en) Substituted benzylamino nitrogen containing non-aromatic heterocycles
ATE121385T1 (de) Harnstoffderivate, ihre herstellung und ihre verwendung bei der therapie.
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
UA66888C2 (uk) 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
MX9800705A (es) Compuestos heterociclicos, composiciones para tratar isquemia de miocardio que los contiene, y procedimiento para su preparacion.
ATE264840T1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69902142D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
CA2171972A1 (en) Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee